These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32271814)

  • 1. Effect of treatment modality and cerebral vasospasm agent on patient outcomes after aneurysmal subarachnoid hemorrhage in the elderly aged 75 years and older.
    Ido K; Kurogi R; Kurogi A; Nishimura K; Arimura K; Nishimura A; Ren N; Kada A; Matsuo R; Onozuka D; Hagihara A; Takagishi S; Yamagami K; Takegami M; Nohara Y; Nakashima N; Kamouchi M; Date I; Kitazono T; Iihara K;
    PLoS One; 2020; 15(4):e0230953. PubMed ID: 32271814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Matsuda N; Naraoka M; Ohkuma H; Shimamura N; Ito K; Asano K; Hasegawa S; Takemura A
    Cerebrovasc Dis; 2016; 42(1-2):97-105. PubMed ID: 27070952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage.
    Hoh BL; Topcuoglu MA; Singhal AB; Pryor JC; Rabinov JD; Rordorf GA; Carter BS; Ogilvy CS
    Neurosurgery; 2004 Oct; 55(4):779-86; discussion 786-9. PubMed ID: 15458586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficiency of cilostazol for cerebral vasospasm following subarachnoid hemorrhage].
    Murahashi T; Kamiyama K; Hara K; Ozaki M; Mikamoto M; Nakagaki Y; Nakagaki Y; Nakamura H
    No Shinkei Geka; 2013 May; 41(5):393-400. PubMed ID: 23648655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage.
    Iwabuchi S; Hayashi M; Yokouchi T; Sato K; Nakayama H; Harashina J; Iwama J; Ishii M; Hiramoto Y; Hirai N; Hirata Y; Saito N; Ito K; Kimura H; Aoki K
    Acta Neurochir Suppl; 2015; 120():167-9. PubMed ID: 25366618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of treatment modality on in-hospital outcome in patients with subarachnoid hemorrhage: a nationwide study in Japan (J-ASPECT Study).
    Kurogi R; Kada A; Nishimura K; Kamitani S; Nishimura A; Sayama T; Nakagawara J; Toyoda K; Ogasawara K; Ono J; Shiokawa Y; Aruga T; Miyachi S; Nagata I; Matsuda S; Yoshimura S; Okuchi K; Suzuki A; Nakamura F; Onozuka D; Hagihara A; Iihara K;
    J Neurosurg; 2018 May; 128(5):1318-1326. PubMed ID: 28548595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil hydrochloride and ozagrel sodium combination therapy for patients with aneurysmal subarachnoid hemorrhage: a cross-sectional study using a nationwide inpatient database.
    Magara H; Tani T; Imai S; Kiyomi A; Fushimi K; Sugiura M
    J Pharm Health Care Sci; 2024 Aug; 10(1):49. PubMed ID: 39138543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
    Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S
    Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Xu B; Wang R
    Neurol Med Chir (Tokyo); 2006 Sep; 46(9):421-8. PubMed ID: 16998274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aneurysm treatment modalities on cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Suzuki H; Taki W;
    Acta Neurochir Suppl; 2013; 115():99-105. PubMed ID: 22890654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Various Therapeutic Agents on Vasospasm and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage-Results of a Network Meta-Analysis.
    Mishra S; Garg K; Gaonkar VB; Singh PM; Singh M; Suri A; Chandra PS; Kale SS
    World Neurosurg; 2021 Nov; 155():41-53. PubMed ID: 34339892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, multicenter, randomized study of the efficacy of eicosapentaenoic acid for cerebral vasospasm: the EVAS study.
    Yoneda H; Shirao S; Nakagawara J; Ogasawara K; Tominaga T; Suzuki M
    World Neurosurg; 2014 Feb; 81(2):309-15. PubMed ID: 23032083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive Effect of Clazosentan against Cerebral Vasospasm after Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage in Japanese and Korean Patients.
    Fujimura M; Joo JY; Kim JS; Hatta M; Yokoyama Y; Tominaga T
    Cerebrovasc Dis; 2017; 44(1-2):59-67. PubMed ID: 28463833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage.
    Munakata A; Ohkuma H; Nakano T; Shimamura N; Asano K; Naraoka M
    Neurosurgery; 2009 Mar; 64(3):423-8; discussion 428-9. PubMed ID: 19240603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan.
    Mochizuki T; Ryu B; Shima S; Kamijyo E; Ito K; Ando T; Kushi K; Sato S; Inoue T; Kawashima A; Kawamata T; Okada Y; Niimi Y
    Neurosurg Rev; 2024 Mar; 47(1):113. PubMed ID: 38472507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.